SBP Group (01177) spent HK$10.052 million on May 13 to buy back 1.78 million shares.
China Biotech (01177) announced that it will spend 100.52 million Hong Kong dollars to repurchase 1.78 million shares on May 13, 2026.
SBP GROUP (01177) announced that it will spend 10.52 million Hong Kong dollars to repurchase 1.78 million shares on May 13, 2026.
Related Articles
IMOTIONTECH (01274) spent 369,700 Hong Kong dollars to repurchase 98,800 shares on May 13th.
SINOMEDIA (00623) spent HKD 310,600 to repurchase 152,000 shares on May 13th.
.png)
HENLIUS (02696): The phase I clinical trial of HLX48 (an antibody drug conjugate targeting EGFR and c-MET for the treatment of advanced/metastatic solid tumors) for injection has been approved to be conducted in Australia.
IMOTIONTECH (01274) spent 369,700 Hong Kong dollars to repurchase 98,800 shares on May 13th.
SINOMEDIA (00623) spent HKD 310,600 to repurchase 152,000 shares on May 13th.
HENLIUS (02696): The phase I clinical trial of HLX48 (an antibody drug conjugate targeting EGFR and c-MET for the treatment of advanced/metastatic solid tumors) for injection has been approved to be conducted in Australia.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
